These stocks are moving in today's session
By Mill Chart
Last update: Apr 12, 2024
Friday's session: top gainers and losers
Gainers
| Ticker | Change | Comment |
|---|---|---|
| CISS | 6.0K% | Positive market sentiment drove C3IS INC's (NASDAQ:CISS) stock price up by 6.0K% to $1.8 during Friday's session. In the last month the stock lost 68.0%. |
| EZGO | 5.0K% | Investors celebrated as EZGO TECHNOLOGIES LTD (NASDAQ:EZGO) experienced a 5.0K% rise in its shares, closing at $2.05 during Friday's session. The stock is trading 58.47% lower than a month ago. |
| AGEN | 2.0K% | AGENUS INC's (NASDAQ:AGEN) stock price displayed strong growth, advancing 2.0K% and reaching $8.53 during Friday's session. A press release (Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer) was released earlier today. |
| FLNT | 434.0% | FLUENT INC's (NASDAQ:FLNT) shares soared 434.0% to $2.67 during Friday's session. Shareholders saw the stock price going 32.1% lower in the past 3 months. |
| TPET | 152.0% | TRIO PETROLEUM CORP (NYSEARCA:TPET) rose 152.0% to $0.58 during Friday's after hours session. Shareholders saw the stock price going 108.0% higher in the past month. |
| PXMD | 106.0% | Investors celebrated as PAXMEDICA INC (NASDAQ:PXMD) experienced a 106.0% rise in its shares, closing at $0.85 during Friday's session. A press release (PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission) was released yesterday. |
| STIXW | 50.38% | ALPHA CAPIT -27's (NASDAQ:STIXW) shares rose 50.38% to $0.02 during Friday's session. The stock is trading 68.41% lower than 6 months ago. |
| BENF | 41.82% | BENEFICIENT - CLASS A (NASDAQ:BENF) rose 41.82% to $0.1 during Friday's after hours session. In the last 3 months the share price dropped with 83.15%. |
| CNXA | 32.42% | CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) shares rose 32.42% to $1.43 during Friday's session. The stock is trading 376.0% higher than a month ago. |
| HNRA | 31.29% | Positive market sentiment drove HNR ACQUISITION CORP's (NYSEARCA:HNRA) stock price up by 31.29% to $3.0 during Friday's session. The stock is trading 25.57% lower than a month ago. |
For the full top gainers list go to our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| MOTS | -37.31% | MOTUS GI HOLDINGS INC's (NASDAQ:MOTS) shares fell 37.31% to $0.27 during Friday's session. In the last month the stock lost 33.01%. |
| MI | -29.66% | NFT LTD-A's (NYSEARCA:MI) stock price decreased by 29.66% to $5.1. In the last month the stock lost 40.23%. |
| LXEH | -29.54% | During Friday's session, LIXIANG EDUCATION HOLDIN-ADR's (NASDAQ:LXEH) shares took a tumble, falling 29.54% to $0.46. The stock is trading 86.92% lower than a month ago. |
| RLYB | -28.52% | Investors witnessed a 28.52% drop in RALLYBIO CORP's (NASDAQ:RLYB) stock price, which closed at $2.13 during Friday's session. Two days ago the company had a press release: Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). |
| MGRM | -25.06% | MONOGRAM ORTHOPAEDICS INC's (NASDAQ:MGRM) stock price decreased by 25.06% to $3.05. In the last month the share price increased with 76.19%. |
| SLNH | -23.53% | The market experienced a 23.53% downturn in SOLUNA HOLDINGS INC's (NASDAQ:SLNH) stock price, closing at $1.69 during Friday's session. The stock is trading 36.86% lower than a month ago. |
| GDHG | -21.74% | During Friday's session, GOLDEN HEAVEN GROUP HOLDINGS's (NASDAQ:GDHG) shares took a tumble, falling 21.74% to $0.23. The stock is trading 38.98% lower than a month ago. |
| ENLV | -21.31% | ENLIVEX THERAPEUTICS LTD's (NASDAQ:ENLV) shares fell 21.31% to $1.44 during Friday's session. A press release (Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis) was released yesterday. |
| MDIA | -21.04% | MEDIACO HOLDING INC-CL A's (NASDAQ:MDIA) stock price decreased by 21.04% to $2.89. The stock is trading 663.0% higher than a month ago. |
| AWIN | -20.19% | AERWINS TECHNOLOGY INC's (NASDAQ:AWIN) stock price faced a 20.19% decline, reaching $3.36 during Friday's session. In the last month the stock lost 50.53%. |
Our top losers page will show you the full list.
ENLIVEX THERAPEUTICS LTD
NASDAQ:ENLV (4/29/2024, 7:00:01 PM)
Premarket: 1.65 -0.01 (-0.6%)1.66
+0.22 (+15.28%)
ENLV News
22 hours ago - Enlivex Therapeutics LtdEnlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events8 days ago - Enlivex Therapeutics LtdEnlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
13 days ago - ChartmillOn Wednesday, there are stocks with unusual volume. Let's take a look.Let's have a look at the stocks with an unusual volume in today's session.
14 days ago - Enlivex Therapeutics LtdEnlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee OsteoarthritisNes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Company’s multi-country, randomized, controlled Phase I/II trial evaluating AllocetraTM in up to 160 patients with moderate to severe knee osteoarthritis. As previously announced, the Company received its first regulatory approval for this trial from the Israeli Ministry of Health (IMOH) in January.
15 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?Which stocks are moving on Monday?
18 days ago - ChartmillThese stocks are moving in today's sessionFriday's session: top gainers and losers
19 days ago - Enlivex Therapeutics LtdEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with SepsisNes-Ziona, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
19 days ago - Enlivex Therapeutics LtdEnlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With SepsisAnalysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety...
25 days ago - InvestorPlaceENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023ENLV stock results show that Enlivex Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
